Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (591-600 of 853) with videos related to

Pageof 86
Sort By:
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full reportS Rauz, S-Y Koay, B Foot, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
American Journal of Ophthalmology Case Reports|May 22, 2020
Shotgun sequencing to determine corneal infectionMohit Parekh, Vito Romano, Antonella Franch, et al.
Journal of Medical Virology|September 13, 2002
Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infectionC E Willoughby, K Baker, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
BMJ Open Ophthalmology|July 6, 2019
Metagenomics in ophthalmology: current findings and future prospectivesDavide Borroni, Vito Romano, Stephen B Kaye, et al.
British Journal of Cancer|February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumoursD A Anthoney, M J McKean, J T Roberts, et al.
Gynecologic Oncology|October 1, 1983
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapyM Friedlander, S B Kaye, A Sullivan, et al.
Journal of Medical Virology|August 27, 2005
Evidence for persistence of adenovirus in the tear film a decade following conjunctivitisStephen B Kaye, Marianne Lloyd, Helen Williams, et al.
Pageof 86

Showing results (591-600 of 853) with videos related to

Sort By:
Pageof 86
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full reportS Rauz, S-Y Koay, B Foot, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
American Journal of Ophthalmology Case Reports|May 22, 2020
Shotgun sequencing to determine corneal infectionMohit Parekh, Vito Romano, Antonella Franch, et al.
Journal of Medical Virology|September 13, 2002
Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infectionC E Willoughby, K Baker, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
BMJ Open Ophthalmology|July 6, 2019
Metagenomics in ophthalmology: current findings and future prospectivesDavide Borroni, Vito Romano, Stephen B Kaye, et al.
British Journal of Cancer|February 5, 2004
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumoursD A Anthoney, M J McKean, J T Roberts, et al.
Gynecologic Oncology|October 1, 1983
Cervical carcinoma: a drug-responsive tumor--experience with combined cisplatin, vinblastine, and bleomycin therapyM Friedlander, S B Kaye, A Sullivan, et al.
Journal of Medical Virology|August 27, 2005
Evidence for persistence of adenovirus in the tear film a decade following conjunctivitisStephen B Kaye, Marianne Lloyd, Helen Williams, et al.
Pageof 86